Patent · US Active

KRAS G12C inhibitors and methods of using the same

US10988485B2 · kind B2 · utility

22Cited by

45References

51Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Ana Elena Minatti · Santa Monica, US
Jonathan D. Low · Thousand Oaks, US
Ryan Wurz · Newbury Park, US
Brian Alan LANMAN · Calabasas, US
Victor J. Cee · Thousand Oaks, US
Michael D. Bartberger · West Hollywood, US
Margaret Chu-Moyer · Brookline, US

Key dates

Filing date	May 9, 2019
Grant date	Apr 27, 2021
Priority date	—
Expiry date	May 9, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/2896
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.